{"transactions":[{"id":741777,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:17.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001751873-26-000002","document":"form4-06112026_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175187326000002/form4-06112026_040606.xml","form_type":"4"}},{"id":1113581,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:30:18.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-016956","document":"form4-06122025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925016956/form4-06122025_040606.xml","form_type":"4"}},{"id":1477397,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:00:19.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-017238","document":"form4-06172024_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924017238/form4-06172024_050614.xml","form_type":"4"}},{"id":1561950,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:09:14.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":1300,"price":3.7429,"value":4865.77,"ownership":{"direct":true},"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001415889-24-009062","document":"form4-03252024_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588924009062/form4-03252024_110307.xml","form_type":"4"}},{"id":1870161,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:31:35.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033781/doc4.xml","form_type":"4"}},{"id":2209045,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T16:04:56.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.98,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-22-078788","document":"tm2220760-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922078788/tm2220760-2_4seq1.xml","form_type":"4"}},{"id":2209044,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T16:04:56.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":17307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":17307},"source":{"system":"sec-edgar","filing":"0001104659-22-078788","document":"tm2220760-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922078788/tm2220760-2_4seq1.xml","form_type":"4"}},{"id":2209043,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T16:04:56.000Z","date":"2022-07-11","kind":"disposition_to_issuer","acquired":false,"shares":27500,"price":2.2,"value":60500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078788","document":"tm2220760-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922078788/tm2220760-2_4seq1.xml","form_type":"4"}},{"id":2209042,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T16:04:56.000Z","date":"2022-07-07","kind":"other","acquired":false,"shares":22000,"price":2.2,"value":48400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078788","document":"tm2220760-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922078788/tm2220760-2_4seq1.xml","form_type":"4"}},{"id":2230089,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Berger Heather A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:05:42.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037503/doc4.xml","form_type":"4"}},{"id":2393821,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T16:02:06.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":5769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 7,500 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 5,769 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date."}],"balance_after":5769,"derivative":{"exercise_price":2.44,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":5769},"source":{"system":"sec-edgar","filing":"0001104659-22-023772","document":"tm226724-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922023772/tm226724-4_4seq1.xml","form_type":"4"}},{"id":2393820,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T16:02:06.000Z","date":"2021-07-16","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 7,500 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 5,769 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-22-023772","document":"tm226724-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922023772/tm226724-4_4seq1.xml","form_type":"4"}},{"id":2393819,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T16:02:06.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":11538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on January 18, 2019. In exchange, the Reporting Person received a replacement option for 11,538 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date."}],"balance_after":11538,"derivative":{"exercise_price":2.44,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001104659-22-023772","document":"tm226724-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922023772/tm226724-4_4seq1.xml","form_type":"4"}},{"id":2393818,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T16:02:06.000Z","date":"2021-07-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on January 18, 2019. In exchange, the Reporting Person received a replacement option for 11,538 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provided for vesting as follows: The shares subject to this option will vest in full on January 1, 2020, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.66,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-023772","document":"tm226724-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922023772/tm226724-4_4seq1.xml","form_type":"4"}},{"id":2431743,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T16:02:48.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service as a director of the Company."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001104659-22-005418","document":"tm223320-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465922005418/tm223320-6_4seq1.xml","form_type":"4"}},{"id":2666469,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:17:58.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over a three year period following June 15, 2021 (the \"Grant Date\") such that the option is fully vested on the third anniversary of the Grant Date."}],"balance_after":30000,"derivative":{"exercise_price":27.04,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-040988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121040988/doc4.xml","form_type":"4"}},{"id":2760319,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T10:35:46.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001104659-21-045914","document":"tm2111994-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465921045914/tm2111994-3_4seq1.xml","form_type":"4"}},{"id":3011312,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T16:32:29.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the  next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":2.98,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-20-112659","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465920112659/a4.xml","form_type":"4"}},{"id":3480875,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T16:03:22.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the  next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-037004","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000110465919037004/a4.xml","form_type":"4"}},{"id":3690390,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":39299,"kind":"person","name":"Berger Heather A.","position":1,"cik":"0001751873","reported_name":"Behanna Heather","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-22T16:56:15.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest on January 1, 2020, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":15000,"derivative":{"exercise_price":5.66,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-004765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724344/000120919119004765/doc4.xml","form_type":"4"}}]}